Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 104.66 · gapped above the open, then crossed back over prior close. High/low 107.70 at 4:45 am ET, 104.27 at 3:15 pm ET.
269 institutional managers report a position in Dianthus Therapeutics, Inc. worth $6.5B between them, filed on form 13F for the quarter ending 2026-06-30. 36 of them hold 80% of it, the largest being FMR LLC at 12.38%.
244 more managers in the register
36 managers hold 80% of the $6.5B institutional base. The other 233 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
Dianthus Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
DNTH (Dianthus Therapeutics, Inc.) has 2 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
via T. Rowe Price Investment Management, Inc., Wellington Management Group LLP, TCG Crossover Management, LLC +13 more · 5.87% of DNTH, 6.69% of CGON
via T. Rowe Price Investment Management, Inc., Wellington Management Group LLP, Octagon Capital Advisors LP +8 more · 5.87% of DNTH, 6.00% of AKTS
via Fairmount Funds Management LLC, TCG Crossover Management, LLC, Wellington Management Group LLP +15 more · 3.83% of DNTH, 2.82% of COGT
via Fairmount Funds Management LLC, VR Adviser, LLC, Polar Capital Holdings Plc +16 more · 3.83% of DNTH, 4.98% of ORKA
via Wellington Management Group LLP, T. Rowe Price Investment Management, Inc., Deerfield Management Co +8 more · 4.88% of DNTH, 5.00% of AVLN
via T. Rowe Price Investment Management, Inc., VR Adviser, LLC, Logos Global Management LP +13 more · 5.87% of DNTH, 7.33% of ERAS
Managers holding a meaningful stake in DNTH also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.